跳至主要内容
临床试验/CTRI/2025/01/079374
CTRI/2025/01/079374已完成Unknown

In-use test to study the user rating for Plum Niacinamide Tinted Sunscreen

Pureplay Skin Sciences Pvt Ltd1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年2月3日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
User Ratings

研究概览

简要总结

It is a User Rating based trial where, healthy volunteers are enrolled

Consumer self evaluation were assesses-

  1. X% users felt their skin looked instantly bright and even toned.

  2. X% said the formula blended seamlessly into their skin tone.

  3. X% users agreed that the sunscreen is perfect for Indian skin tones.

  4. X % users agreed that the sunscreen enhanced skin smoothness and visibly blurred skin texture

  5. X% found the sunscreen lightweight and comfortable for all-day wear.

  6. X% said their skin felt hydrated and smooth without greasiness.

  7. X% agreed it provided reliable protection throughout the day without needing frequent reapplication.

  8. X% noticed brighter and healthier-looking skin after X days of regular use.

  9. X% confirmed the tint adapted well to their skin tone, leaving no white cast.

  10. X% users confirmed that their makeup didn’t budge after using this sunscreen as base.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)

入选标准

  • Gender: Non-pregnant, non-lactating female aged between 18 to 45 (Female:Male ratio to be 80:20) 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3.Have open sores or open lesions in the treatment area(s).
  • 4.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 5.Have participated in any interventional clinical trial in the previous 30 days.
  • 6.Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient’s name) 7.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 8.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

结局指标

主要结局

User Ratings

时间窗: T+7days

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
Pureplay Skin Sciences Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验